4//SEC Filing
Snider Lindy 4
Accession 0001214659-18-005901
CIK 0001625288other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 5:04 PM ET
Size
9.6 KB
Accession
0001214659-18-005901
Insider Transaction Report
Form 4
Snider Lindy
Director
Transactions
- Other
Class C Warrants (right to buy)
2018-08-08−40,000→ 0 totalExercise: $0.50From: 2017-11-29Exp: 2018-08-08→ Common Stock (40,000 underlying) - Other
Class D Warrants (right to buy)
2018-08-08+40,000→ 40,000 totalExercise: $1.00From: 2018-08-08Exp: 2018-09-28→ Units (40,000 underlying)
Holdings
- 100,000
Stock option - right to buy
Exercise: $0.54From: 2018-07-25Exp: 2023-07-25→ Common Stock (100,000 underlying) - 480,000
Common Stock
Footnotes (3)
- [F1]25,000 options vested immediately, with the remainder vesting quarterly over the next 6 quarters beginning with the quarter ending September 30, 2018.
- [F2]Each unit consists of one share of common stock and one Class E Warrant.
- [F3]Class C Warrants were exchanged for an equal number of Class D Warrants.
Documents
Issuer
Intiva BioPharma Inc.
CIK 0001625288
Entity typeother
Related Parties
1- filerCIK 0001733367
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 5:04 PM ET
- Size
- 9.6 KB